Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway.

@article{He2016DaidzeinEA,
  title={Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway.},
  author={Y. He and X. Wu and Y X Cao and Yichao Hou and Helen Chen and L Wu and L Lu and W. Zhu and Y. Gu},
  journal={Neoplasma},
  year={2016},
  volume={63 4},
  pages={
          523-31
        }
}
Bladder cancer is one of the causes of cancer‑related death and has a high mortality rate. Daidzein, a natural isoflavone compound predominantly extracted from soybeans, has been reported to exhibit several bioactivities, including anti-tumor. However, the effects of daidzein on bladder cancer remains unrevealed. Here we investigated the effects and molecular mechanisms of daidzein on bladder cancer using multiple in vitro cell lines and in vivo xenograft mice studies. Our results showed that… Expand
Investigation of inhibition effect of daidzein on osteosarcoma cells based on experimental validation and systematic pharmacology analysis
TLDR
In vitro, daidzein significantly inhibited 143B and U2OS osteosarcoma cell proliferation and migration, and induced cell cycle arrest, and the mechanism may be through the Src-ERK pathway. Expand
Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.
TLDR
Results suggest that formononetin exerts an anti-carcinogenic effect on BCa in vitro, which might be due to miR-21-mediated regulation of the PTEN/Akt pathway. Expand
Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
  • Xiaodan Shi, Yuanyuan Zhang, +7 authors Dong Joon Kim
  • Medicine
  • Frontiers in Oncology
  • 2021
TLDR
It is reported that Ipriflavone is a novel mammalian target of rapamycin (mTOR) inhibitor that suppresses cell proliferation and induces cell apoptosis in ESCC cells and strongly inhibited ESCC patient-derived xenograft tumor growth in an in vivo mouse model. Expand
Daidzein inhibits choriocarcinoma proliferation by arresting cell cycle at G1 phase through suppressing ERK pathway in vitro and in vivo.
TLDR
Results in this study demonstrate daidzein can inhibit choriocarcinoma cell proliferation in vitro and in-vivo; underlying mechanism behind the inhibitory effects may probably be suppressing ERK pathway and afterwards arresting cell cycle at G1 phase. Expand
Biphasic Effects of Phytochemicals and their Relevance to Cancer Therapeutics
Cancer is one of the most deadly diseases caused worldwide. Enormous active anti-cancer agents that are available in nature play an efficient role in therapies associated to cancer for differentExpand
Daidzein induces choriocarcinoma cell apoptosis in a dose-dependent manner via the mitochondrial apoptotic pathway.
TLDR
The results of the present study demonstrate that daidzein may induce apoptosis of choriocarcinoma cells in a dose‑dependent manner via the mitochondrial apoptotic pathway. Expand
MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
TLDR
The results suggest that the miR-99a/FGFR3 axis is an important tumor regulator in breast cancer and might have potential as a therapeutic target. Expand
Therapeutic Potential of Isoflavones with an Emphasis on Daidzein
TLDR
The present review is aimed at providing a deepen analysis of daidzein pharmacodynamics and its implications in human health, from its best-known effects alleviating postmenopausal symptoms to its potential anticancer and antiaging properties. Expand
Daidzein alleviates cisplatin‐induced muscle atrophy by regulating Glut4/AMPK/FoxO pathway
TLDR
Results suggest that DAI can alleviate DDP‐induced skeletal muscle atrophy by downregulating the expression of Atrogin1 and MuRF1 through the regulation of Glut4/AMPK/FoxO pathway. Expand
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
TLDR
CD KN2A RNA expression-based risk stratification of MIBC allows the identification of a CDKN2Ahigh poor prognosis group with low expression of drug target genes. Expand
...
1
2
...

References

SHOWING 1-10 OF 39 REFERENCES
Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro
TLDR
Daidzein affected human nonhormone-dependent cervical cancer cells in several ways, including cell growth, cell cycle, and telomerase activity in vitro, which showed that the inductive effects of apoptosis were more obviously observed in low-concentration groups. Expand
Antitumor activity of fibroblast growth factor receptor 3–specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis
TLDR
Results show that FGFR3-driven immunotoxins may be an effective therapeutic agent against human bladder and other tumor types overexpressingFGFR3. Expand
Daidzein, R-(+)equol and S-(−)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2
TLDR
Daidzein, R- and S-equol inhibit the invasion of MDA-MB-231 human breast cancer cells in part via the down-regulation of MMP-2 expression, with equipotent effects observed for the parent isoflavone daidze in and the equol enantiomers. Expand
Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.
TLDR
The c-MYC inhibitor KSI-3716 could be developed as an effective intravesical chemotherapy agent for bladder cancer. Expand
Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function.
TLDR
In a macrophage cell line activated with interferon gamma plus lipopolysaccharide, both isoflavones were found to inhibit NO production and tumour necrosis factor alpha secretion dose-dependently, but they did not affect mRNA levels for inducible nitric oxide synthase and cyclo-oxygenase-2. Expand
Up‐regulation of p21WAF1/CIP1 by miRNAs and its implications in bladder cancer cells
TLDR
The expression levels of three miRNAs decreased in bladder cancer tissues compared to healthy controls and the levels of these mRNAs positively correlated with p21 mRNA levels, which indicates these mi RNAs could be candidates for anti‐cancer drugs. Expand
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
TLDR
The incorporation of specific patient selection biomakers with the rationale for therapeutic intervention with FGFR-targeted therapy in breast cancer is endorsed. Expand
The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy.
TLDR
The hollow mesoporous silica nanospheres (HMSNs) in encapsulating BTZ for drug delivery are reported as a promising platform to deliver therapeutic agents for beneficial clinical outcomes through lowering doses and frequency of drug administration and reducing potential side effects. Expand
Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects.
  • G. Karikas
  • Biology, Medicine
  • Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • 2010
TLDR
Current approaches towards natural anticancer agents in clinical practice, new candidate oncotherapy drugs from plants, marine and microorganisms, as well as promising chemopreventing agents from nature are dealt with. Expand
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
TLDR
The development of BXI(s) as a new class of anticancer agents is warranted and represents a novel strategy for improving lung cancer outcome. Expand
...
1
2
3
4
...